Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy

ACS Nano

Volumn 11, Issue 1, 2017, Pages 927-937

  Feng, Liangzhu ^a,b   Cheng, Liang ^a,c   Dong, Ziliang ^a   Tao, Danlei ^a   Barnhart, Todd E ^c   Cai, Weibo ^c   Chen, Meiwan ^b   Liu, Zhuang ^a  

^a SOOCHOW UNIVERSITY   (China)

^b University of Macau   (Macao)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

hypoxia activated therapy; liposomes; multimodal imaging; photodynamic therapy; tumor hypoxia

Indexed keywords

CHEMOTHERAPY; DISEASES; HYDROPHOBICITY; LIGHT EMITTING DIODES; LIPOSOMES; MEDICAL NANOTECHNOLOGY; PHOTOSENSITIZERS; POSITRON EMISSION TOMOGRAPHY; TUMORS;

HYPOXIA-ACTIVATED THERAPY; HYPOXIC ENVIRONMENTS; INTRAVENOUS INJECTIONS; MULTI-MODAL IMAGING; PHOTO-ACOUSTIC IMAGING; PHOTODYNAMIC THERAPY (PDT); THERANOSTIC NANOMEDICINE; TUMOR HYPOXIA;

PHOTODYNAMIC THERAPY;

AMINE; ANTINEOPLASTIC AGENT; HEXADECYLAMINE; HYDROCARBON; LIPOSOME; PHOTOSENSITIZING AGENT; PRODRUG;

ANIMAL; BREAST TUMOR; CELL PROLIFERATION; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HYPOXIA; METABOLISM; MOUSE; PATHOLOGY; PHOTOCHEMOTHERAPY; POSITRON EMISSION TOMOGRAPHY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; THERANOSTIC NANOMEDICINE; TUMOR CELL LINE;

AMINES; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYDROCARBONS; HYPOXIA; LIPOSOMES; MICE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POSITRON-EMISSION TOMOGRAPHY; PRODRUGS; STRUCTURE-ACTIVITY RELATIONSHIP; THERANOSTIC NANOMEDICINE;

EID: 85018193444     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/acsnano.6b07525     Document Type: Article

References (52)

1. Semenza, G. L. The Hypoxic Tumor Microenvironment: A Driving Force for Breast Cancer Progression Biochim. Biophys. Acta, Mol. Cell Res. 2016, 1863, 382-391 10.1016/j.bbamcr.2015.05.036
2. Brown, J. M.; Giaccia, A. J. The Unique Physiology of Solid Tumors: Opportunities (and Problems) for Cancer Therapy Cancer Res. 1998, 58, 1408-1416
3. Swartz, M. A.; Iida, N.; Roberts, E. W.; Sangaletti, S.; Wong, M. H.; Yull, F. E.; Coussens, L. M.; DeClerck, Y. A. Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy Cancer Res. 2012, 72, 2473-2480 10.1158/0008-5472.CAN-12-0122
4. Brown, J. M.; Wilson, W. R. Exploiting Tumour Hypoxia in Cancer Treatment Nat. Rev. Cancer 2004, 4, 437-447 10.1038/nrc1367
5. Wilson, W. R.; Hay, M. P. Targeting Hypoxia in Cancer Therapy Nat. Rev. Cancer 2011, 11, 393-410 10.1038/nrc3064
6. Harris, A. L. Hypoxia: A Key Regulatory Factor in Tumour Growth Nat. Rev. Cancer 2002, 2, 38-47 10.1038/nrc704
7. Patel, A.; Sant, S. Hypoxic Tumor Microenvironment: Opportunities to Develop Targeted Therapies Biotechnol. Adv. 2016, 34, 803-812 10.1016/j.biotechadv.2016.04.005
8. Huang, C.-C.; Chia, W.-T.; Chung, M.-F.; Lin, K.-J.; Hsiao, C.-W.; Jin, C.; Lim, W.-H.; Chen, C.-C.; Sung, H.-W. An Implantable Depot That Can Generate Oxygen in Situ for Overcoming Hypoxia-Induced Resistance to Anticancer Drugs in Chemotherapy J. Am. Chem. Soc. 2016, 138, 5222-5225 10.1021/jacs.6b01784
9. Kumar, R.; Kim, E.-J.; Han, J.; Lee, H.; Shin, W. S.; Kim, H. M.; Bhuniya, S.; Kim, J. S.; Hong, K. S. Hypoxia-Directed and Activated Theranostic Agent: Imaging and Treatment of Solid Tumor Biomaterials 2016, 104, 119-128 10.1016/j.biomaterials.2016.07.010
10. Song, X.; Feng, L.; Liang, C.; Gao, M.; Song, G.; Liu, Z. Liposomes Co-Loaded with Metformin and Chlorin e6 Modulate Tumor Hypoxia during Enhanced Photodynamic Therapy Nano Res. 2016, 10.1007/s12274-016-1274-8
11. Fan, W.; Bu, W.; Shi, J. On The Latest Three-Stage Development of Nanomedicines Based on Upconversion Nanoparticles Adv. Mater. 2016, 28, 3987-4011 10.1002/adma.201505678
12. Denny, W. A. The Role of Hypoxia-Activated Prodrugs in Cancer Therapy Lancet Oncol. 2000, 1, 25-29 10.1016/S1470-2045(00)00006-1
13. Weiss, G. J.; Infante, J. R.; Chiorean, E. G.; Borad, M. J.; Bendell, J. C.; Molina, J. R.; Tibes, R.; Ramanathan, R. K.; Lewandowski, K.; Jones, S. F.; Lacouture, M. E.; Langmuir, V. K.; Lee, H.; Kroll, S.; Burris, H. A. Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of TH-302, A Hypoxia-Activated Prodrug, in Patients with Advanced Solid Malignancies Clin. Cancer Res. 2011, 17, 2997-3004 10.1158/1078-0432.CCR-10-3425
14. Denny, W. A. Hypoxia-Activated Prodrugs in Cancer Therapy: Progress to the Clinic Future Oncol. 2010, 6, 419-428 10.2217/fon.10.1
15. Ganjoo, K. N.; Cranmer, L. D.; Butrynski, J. E.; Rushing, D.; Adkins, D.; Okuno, S. H.; Lorente, G.; Kroll, S.; Langmuir, V. K.; Chawla, S. P. A Phase I Study of the Safety and Pharmacokinetics of the Hypoxia-Activated Prodrug TH-302 in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma Oncology 2011, 80, 50-56 10.1159/000327739
16. Chawla, S. P.; Cranmer, L. D.; Van Tine, B. A.; Reed, D. R.; Okuno, S. H.; Butrynski, J. E.; Adkins, D. R.; Hendifar, A. E.; Kroll, S.; Ganjoo, K. N. Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma J. Clin. Oncol. 2014, 32, 3299-3306 10.1200/JCO.2013.54.3660
17. Borad, M. J.; Reddy, S. G.; Bahary, N.; Uronis, H. E.; Sigal, D.; Cohn, A. L.; Schelman, W. R.; Stephenson, J.; Chiorean, E. G.; Rosen, P. J.; Ulrich, B.; Dragovich, T.; Del Prete, S. A.; Rarick, M.; Eng, C.; Kroll, S.; Ryan, D. P. Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer J. Clin. Oncol. 2015, 33, 1475-1481 10.1200/JCO.2014.55.7504
18. Williams, K. J.; Albertella, M. R.; Fitzpatrick, B.; Loadman, P. M.; Shnyder, S. D.; Chinje, E. C.; Telfer, B. A.; Dunk, C. R.; Harris, P. A.; Stratford, I. J. In vivo Activation of the Hypoxia-Targeted Cytotoxin AQ4N in Human Tumor Xenografts Mol. Cancer Ther. 2009, 8, 3266-3275 10.1158/1535-7163.MCT-09-0396
19. Yuan, Y.; Zhang, C.-J.; Kwok, R. T. K.; Xu, S.; Zhang, R.; Wu, J.; Tang, B. Z.; Liu, B. Light-Up Probe for Targeted and Activatable Photodynamic Therapy with Real-Time In Situ Reporting of Sensitizer Activation and Therapeutic Responses Adv. Funct. Mater. 2015, 25, 6586-6595 10.1002/adfm.201502728
20. Dougherty, T. J.; Gomer, C. J.; Henderson, B. W.; Jori, G.; Kessel, D.; Korbelik, M.; Moan, J.; Peng, Q. Photodynamic Therapy J. Natl. Cancer Inst. 1998, 90, 889-905 10.1093/jnci/90.12.889
21. Dolmans, D. E. J. G. J.; Fukumura, D.; Jain, R. K. Photodynamic Therapy for Cancer Nat. Rev. Cancer 2003, 3, 380-387 10.1038/nrc1071
22. Cheng, L.; Wang, C.; Feng, L.; Yang, K.; Liu, Z. Functional Nanomaterials for Phototherapies of Cancer Chem. Rev. 2014, 114, 10869-10939 10.1021/cr400532z
23. Feng, B.; Zhou, F.; Wang, D.; Xu, Z.; Yu, H.; Li, Y. Gold Nanomaterials for Treatment of Metastatic Cancer Sci. China: Chem. 2016, 59, 984 10.1007/s11426-016-5593-0
24. Yuan, Y.; Feng, G.; Qin, W.; Tang, B. Z.; Liu, B. Targeted and Image-Guided Photodynamic Cancer Therapy Based on Organic Nanoparticles with Aggregation-Induced Emission Characteristics Chem. Commun. 2014, 50, 8757-8760 10.1039/C4CC02767A
25. Wang, D.; Wang, T.; Liu, J.; Yu, H.; Jiao, S.; Feng, B.; Zhou, F.; Fu, Y.; Yin, Q.; Zhang, P.; Zhang, Z.; Zhou, Z.; Li, Y. Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy Nano Lett. 2016, 16, 5503-5513 10.1021/acs.nanolett.6b01994
26. Ai, X.; Ho, C. J. H.; Aw, J.; Attia, A. B. E.; Mu, J.; Wang, Y.; Wang, X.; Wang, Y.; Liu, X.; Chen, H.; Gao, M.; Chen, X.; Yeow, E. K. L.; Liu, G.; Olivo, M.; Xing, B. In vivo Covalent Cross-Linking of Photon-Converted Rare-Earth Nanostructures for Tumour Localization and Theranostics Nat. Commun. 2016, 7, 10432-10440 10.1038/ncomms10432
27. Ai, X.; Mu, J.; Xing, B. Recent Advances of Light-Mediated Theranostics Theranostics 2016, 6, 2439-2457 10.7150/thno.16088
28. Foster, T. H.; Murant, R. S.; Bryant, R. G.; Knox, R. S.; Gibson, S. L.; Hilf, R. Oxygen Consumption and Diffusion Effects in Photodynamic Therapy Radiat. Res. 1991, 126, 296-303 10.2307/3577919
29. Foster, T. H.; Gao, L. Dosimetry in Photodynamic Therapy: Oxygen and the Critical Importance of Capillary Density Radiat. Res. 1992, 130, 379-383 10.2307/3578385
30. Song, X.; Chen, Q.; Liu, Z. Recent Advances in the Development of Organic Photothermal Nano-Agents Nano Res. 2015, 8, 340-354 10.1007/s12274-014-0620-y
31. Song, X.; Feng, L.; Liang, C.; Yang, K.; Liu, Z. Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies Nano Lett. 2016, 16, 6145-6153 10.1021/acs.nanolett.6b02365
32. Cheng, Y.; Cheng, H.; Jiang, C.; Qiu, X.; Wang, K.; Huan, W.; Yuan, A.; Wu, J.; Hu, Y. Perfluorocarbon Nanoparticles Enhance Reactive Oxygen Levels and Tumour Growth Inhibition in Photodynamic Therapy Nat. Commun. 2015, 6, 8785-8792 10.1038/ncomms9785
33. 2-Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy Adv. Mater. 2016, 28, 7129-7136 10.1002/adma.201601902
34. Song, G.; Chen, Y.; Liang, C.; Yi, X.; Liu, J.; Sun, X.; Shen, S.; Yang, K.; Liu, Z. Catalase-Loaded TaOx Nanoshells as Bio-Nanoreactors Combining High-Z Element and Enzyme Delivery for Enhancing Radiotherapy Adv. Mater. 2016, 28, 7143-7148 10.1002/adma.201602111
35. Liu, Y.; Liu, Y.; Bu, W.; Cheng, C.; Zuo, C.; Xiao, Q.; Sun, Y.; Ni, D.; Zhang, C.; Liu, J.; Shi, J. Hypoxia Induced by Upconversion-Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in Tumors Angew. Chem. 2015, 127, 8223-8227 10.1002/ange.201500478
36. Luo, D.; Carter, K. A.; Razi, A.; Geng, J.; Shao, S.; Lin, C.; Ortega, J.; Lovell, J. F. Porphyrin-Phospholipid Liposomes with Tunable Leakiness J. Controlled Release 2015, 220, 484-494 10.1016/j.jconrel.2015.11.011
37. Luo, D.; Li, N.; Carter, K. A.; Lin, C.; Geng, J.; Shao, S.; Huang, W.-C.; Qin, Y.; Atilla-Gokcumen, G. E.; Lovell, J. F. Rapid Light-Triggered Drug Release in Liposomes Containing Small Amounts of Unsaturated and Porphyrin-Phospholipids Small 2016, 12, 3039-3047 10.1002/smll.201503966
38. Feng, L.; Gao, M.; Tao, D.; Chen, Q.; Wang, H.; Dong, Z.; Chen, M.; Liu, Z. Cisplatin-Prodrug-Constructed Liposomes as A Versatile Theranostic Nanoplatform for Bimodal Imaging Guided Combination Cancer Therapy Adv. Funct. Mater. 2016, 26, 2207-2217 10.1002/adfm.201504899
39. Patterson, L. H.; McKeown, S. R. AQ4N: A New Approach to Hypoxia-Activated Cancer Chemotherapy Br. J. Cancer 2000, 83, 1589-1593 10.1054/bjoc.2000.1564
40. Cheng, L.; Kamkaew, A.; Sun, H.; Jiang, D.; Valdovinos, H. F.; Gong, H.; England, C. G.; Goel, S.; Barnhart, T. E.; Cai, W. Dual-Modality Positron Emission Tomography/Optical Image-Guided Photodynamic Cancer Therapy with Chlorin e6-Containing Nanomicelles ACS Nano 2016, 10, 7721-7730 10.1021/acsnano.6b03074
41. Liu, T.; Shi, S.; Liang, C.; Shen, S.; Cheng, L.; Wang, C.; Song, X.; Goel, S.; Barnhart, T. E.; Cai, W.; Liu, Z. Iron Oxide Decorated MoS2 Nanosheets with Double PEGylation for Chelator-Free Radiolabeling and Multimodal Imaging Guided Photothermal Therapy ACS Nano 2015, 9, 950-960 10.1021/nn506757x
42. 64Cu-Labeling and Multimodal Image-Guided Photothermal-Radiation Therapy Adv. Funct. Mater. 2016, 26, 2185-2197 10.1002/adfm.201504810
43. Liu, Z.; Cai, W.; He, L.; Nakayama, N.; Chen, K.; Sun, X.; Chen, X.; Dai, H. In vivo Biodistribution and Highly Efficient Tumour Targeting of Carbon Nanotubes in Mice Nat. Nanotechnol. 2007, 2, 47-52 10.1038/nnano.2006.170
44. Keca, J. M.; Chen, J.; Overchuk, M.; Muhanna, N.; MacLaughlin, C. M.; Jin, C. S.; Foltz, W. D.; Irish, J. C.; Zheng, G. Nanotexaphyrin: One-Pot Synthesis of A Manganese Texaphyrin-Phospholipid Nanoparticle for Magnetic Resonance Imaging Angew. Chem. 2016, 128, 6295-6299 10.1002/ange.201600234
45. Gong, H.; Dong, Z.; Liu, Y.; Yin, S.; Cheng, L.; Xi, W.; Xiang, J.; Liu, K.; Li, Y.; Liu, Z. Engineering of Multifunctional Nano-Micelles for Combined Photothermal and Photodynamic Therapy Under the Guidance of Multimodal Imaging Adv. Funct. Mater. 2014, 24, 6492-6502 10.1002/adfm.201401451
46. MacDonald, T. D.; Liu, T. W.; Zheng, G. An MRI-Sensitive, Non-Photobleachable Porphysome Photothermal Agent Angew. Chem., Int. Ed. 2014, 53, 6956-6959 10.1002/anie.201400133
47. Liu, T. W.; MacDonald, T. D.; Shi, J.; Wilson, B. C.; Zheng, G. Intrinsically Copper-64-Labeled Organic Nanoparticles as Radiotracers Angew. Chem., Int. Ed. 2012, 51, 13128-13131 10.1002/anie.201206939
48. Phan, G.; Herbet, A.; Cholet, S.; Benech, H.; Deverre, J.-R.; Fattal, E. Pharmacokinetics of DTPA Entrapped in Conventional and Long-Circulating Liposomes of Different Size for Plutonium Decorporation J. Controlled Release 2005, 110, 177-188 10.1016/j.jconrel.2005.09.029
49. Paoli, E. E.; Kruse, D. E.; Seo, J. W.; Zhang, H.; Kheirolomoom, A.; Watson, K. D.; Chiu, P.; Stahlberg, H.; Ferrara, K. W. An Aptical and MicroPET Assessment of Thermally-Sensitive Liposome Biodistribution in the Met-1 Tumor Model: Importance of Formulation J. Controlled Release 2010, 143, 13-22 10.1016/j.jconrel.2009.12.010
50. Sitnik, T. M.; Hampton, J. A.; Henderson, B. W. Reduction of Tumour Oxygenation during and after Photodynamic Therapy in vivo: Effects of Fluence Rate Br. J. Cancer 1998, 77, 1386-1394 10.1038/bjc.1998.231
51. Jo, J.; Lee, C. H.; Kopelman, R.; Wang, X. In Lifetime-Resolved Photoacoustic (LPA) Spectroscopy for Monitoring Oxygen Change and Photodynamic Therapy (PDT) Proc. SPIE 2016, 97081L 10.1117/12.2213083
52. Henderson, B. W.; Busch, T. M.; Vaughan, L. A.; Frawley, N. P.; Babich, D.; Sosa, T. A.; Zollo, J. D.; Dee, A. S.; Cooper, M. T.; Bellnier, D. A.; Greco, W. R.; Oseroff, A. R. Photofrin Photodynamic Therapy Can Significantly Deplete or Preserve Oxygenation in Human Basal Cell Carcinomas during Treatment, Depending on Fluence Rate Cancer Res. 2000, 60, 525-529